Matthew Call
Chief Operating Officer bij ITEOS THERAPEUTICS, INC.
Vermogen: 1 M $ op 29-02-2024
Profiel
Presently, Matthew A.
Call occupies the position of Chief Operating Officer of iTeos Therapeutics, Inc. and Chief Operating Officer at iTeos Therapeutics SA (a subsidiary of iTeos Therapeutics, Inc.).
In the past he held the position of Principal at General Electric Co., Principal at HP, Inc., Vice President-Marketing & Communications at Endocyte, Inc., Principal at First Data Corp.
and Principal at Disney Enterprises, Inc.
Mr. Call received an undergraduate degree from Brigham Young University and an MBA from Purdue University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
0.39% | 05-12-2023 | 137 898 ( 0.39% ) | 1 M $ | 29-02-2024 |
Actieve functies van Matthew Call
Bedrijven | Functie | Begin |
---|---|---|
ITEOS THERAPEUTICS, INC. | Chief Operating Officer | 01-08-2019 |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Chief Operating Officer | 13-08-2019 |
Eerdere bekende functies van Matthew Call
Bedrijven | Functie | Einde |
---|---|---|
ENDOCYTE, INC. | Chief Operating Officer | - |
Disney Enterprises, Inc.
Disney Enterprises, Inc. Movies/EntertainmentConsumer Services Disney Enterprises, Inc. owns and operates motion pictures, television shows, music, and computer games. It provides animated characters that appear in Disney cartoons, television shows and feature-length motion pictures like Finding Nemo and The Incredibles including Mickey Mouse, Donald Duck, Winnie the Pooh, Buzz Lightyear, Ariel, Aladdin, Timon, and Pumbaa. The company was founded in 1996 and is located in Burbank, CA. | Corporate Officer/Principal | - |
GENERAL ELECTRIC COMPANY | Corporate Officer/Principal | - |
FIRST DATA CORPORATION | Corporate Officer/Principal | - |
HP INC. | Corporate Officer/Principal | - |
Opleiding van Matthew Call
Brigham Young University | Undergraduate Degree |
Purdue University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GENERAL ELECTRIC COMPANY | Producer Manufacturing |
HP INC. | Electronic Technology |
Bedrijven in privébezit | 5 |
---|---|
First Data Corp.
First Data Corp. Regional BanksFinance First Data Corp. provides electronic commerce and payment solutions. It offers credit card processing and solutions, cash advance, data security, payroll delivery, and check acceptance services. The company was founded in 1971 and is headquartered in Atlanta, GA. | Finance |
Disney Enterprises, Inc.
Disney Enterprises, Inc. Movies/EntertainmentConsumer Services Disney Enterprises, Inc. owns and operates motion pictures, television shows, music, and computer games. It provides animated characters that appear in Disney cartoons, television shows and feature-length motion pictures like Finding Nemo and The Incredibles including Mickey Mouse, Donald Duck, Winnie the Pooh, Buzz Lightyear, Ariel, Aladdin, Timon, and Pumbaa. The company was founded in 1996 and is located in Burbank, CA. | Consumer Services |
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Health Technology |
iTeos Therapeutics, Inc. |